Recently several states have legalized recreational and medical marijuana. This has created a confusing set of circumstances due to legalization at the state level, but cannabis is still an illegal schedule 1 drug at the federal level. This confusion also affects the development of analytical methods because there are no clear guidelines available to laboratories. This whitepaper will discuss the following topics: • Overview of state analytical requirements • Discussion of analytical method development for cannabinoids and related compounds of interest • Discussion of method performance
Trending on LCGC: The Top Content of 2024
December 30th 2024In 2024, we launched a content series, covered major conferences, presented prestigious awards, and continued our monthly Analytically Speaking podcasts. Below, you'll find a selection of the most popular content from LCGC International over the past year.